Nuding K
Z Erkr Atmungsorgane. 1981;156(1):59-63.
Report on 6,200 control examinations of patients treated with Ethambutol. Subjective troubles of vision do not influence continuation of therapy. In 8 patients (0,5%) symptoms of neuritis nervioptici accompanied with visus deterioration required to stop therapy (case reports on these 8 patients). Ophthalmologic control examinations are recommended before beginning therapy, during continuous therapy in hospital every eight week, and in case of ambulatory intermitting therapy every third to fourth month.
关于6200例接受乙胺丁醇治疗患者的对照检查报告。视力的主观问题不影响治疗的继续进行。8名患者（0.5%）出现视神经炎症状并伴有视力下降，需要停止治疗（这8名患者的病例报告）。建议在开始治疗前、住院持续治疗期间每八周以及门诊间歇治疗时每三至四个月进行眼科对照检查。
